The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Gout Experts Share Insights Into a Variety of Challenging Gout Scenarios

Gout Experts Share Insights Into a Variety of Challenging Gout Scenarios

June 14, 2022 • By Ruth Jessen Hickman, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
GraphicsRF.com / shutterstock.com

GraphicsRF.com / shutterstock.com

Although the diagnosis and treatment of gout are sometimes straightforward, prac­titioners encounter challenges in patients with atypical presentations, as well as those with medically complex situations or refractory disease. Here, gout experts share insights into some of these scenarios.

You Might Also Like
  • Gout Management Recommendations from the ACR’s 2020 Guideline
  • Gout, Imaging & Cardiovascular Disease: 2 Experts Discuss Challenging Patients & Advanced Imaging
  • Clinical Insights into Gout Management: Q&A with Dr. Tuhina Neogi
Explore This Issue
June 2022
Also By This Author
  • Study Probes New Gene Therapy for Severe, Localized Scleroderma (Morphea)

Flare in Hospitalized Patients

When not contraindicated, the 2020 ACR Guideline for the Management of Gout recommends colchicine, non-steroidal anti-inflammatory drugs (NSAIDs) or glucocorticoids over adrenocorticotropic hormone (ACTH) or interleukin-1 (IL-1) inhibitors, such as anakinra, for the initial treatment of gout flare on the basis of their effectiveness, general tolerability and lower cost.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

However, one treatment challenge is managing a concurrent gout flare in a patient hospitalized for other indications, such as sepsis or acute kidney insufficiency. Such concurrent medical issues can limit treatment options for gout and complicate management, as practitioners must weigh the risks and benefits of different potential treatments in the context of the whole medical picture.

For example, practitioners may hesitate to employ steroids in the context of sepsis for fear of increased infectious com­plications. For acute kidney insufficiency, colchicine and NSAIDs may pose too much of a danger to the kidneys. And some patients have multiple medical contraindications.

Simon M. Helfgott, MD

Dr. Helfgott

Simon M. Helfgott, MD, director of education and fellowship training in the Division of Rheumatology, Inflammation & Immunity, Brigham and Women’s Hospital, Boston, and the former physician editor of The Rheumatologist, notes, “The rheumatologist first needs to sort out all the confounding issues, which may include renal and cardiovascular events, infection and postoperative issues. All these can influence our choice of medications.”

In general, Dr. Helfgott prefers to use colchicine whenever possible. “Given its relatively narrow therapeutic window for patients with renal disease, sometimes we have to choose other drugs,” he adds. His next choice, if not contraindicated, is glucocorticoids. He also notes that NSAIDs should probably be avoided in most hospitalized patients due to risk of bleeding or acute kidney insufficiency.

John D. FitzGerald, MD, PhD, a clinical professor of medicine and clinical chief of the Division of Rheumatology at the University of California, Los Angeles David Geffen School of Medicine, says, “As in the outpatient setting, selecting the anti-inflammatory with fewest side effects is most important.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. FitzGerald notes that steroids would be preferred over colchicine and NSAIDs in most cases of acute kidney insufficiency, but if needed, NSAIDs may be used with caution in some patients on dialysis because they can be dialyzed away. For a mono-articulate gout flare, he prefers to try intra-articular steroids, if not contraindicated.

Anakinra can be another helpful option if colchicine, steroids and NSAIDs all carry high risk, Dr. FitzGerald adds. For example, anakinra may be helpful for a patient with diabetes and chronic kidney disease who is having a polyarticular flare or for other medically complex patients.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Crystal Arthritis Tagged With: Flares, Gout Resource Center, organ transplant, pegloticase, polyarticular arthritis, refractory goutIssue: June 2022

You Might Also Like:
  • Gout Management Recommendations from the ACR’s 2020 Guideline
  • Gout, Imaging & Cardiovascular Disease: 2 Experts Discuss Challenging Patients & Advanced Imaging
  • Clinical Insights into Gout Management: Q&A with Dr. Tuhina Neogi
  • The ACR’s Gout Guideline Co-Author Shares Insight on Treating Pain, Ongoing Patient Care

About Ruth Jessen Hickman, MD

Ruth Jessen Hickman, MD, was born and raised in eastern Kentucky, where she first cultivated her love of literature, writing and personal narratives. She attended Kenyon college, where she received a Bachelor of Arts in philosophy, summa cum laude. She worked with individuals with psychiatric conditions and later in a neuroscience lab at the University of Illinois, Chicago, before graduating from Indiana University Medical School in 2011. Instead of pursuing clinical medicine, Ruth opted to build on her strength of clearly explaining medical topics though a career as a freelance medical writer, writing both for lay people and for health professionals. She writes across the biomedical sciences, but holds strong interests in rheumatology, neurology, autoimmune diseases, genetics, and the intersection of broader social, cultural and emotional contexts with biomedical topics. Ruth now lives in Bloomington, Ind., with her husband, son and cat. She can be contacted via her website at ruthjessenhickman.com.

View more by this author»

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)